Anti-IL-6 Agents Suggested by SITC to Treat Patients with COVID-19

Researchers from SITC suggested the use of anti-IL-6 agents on a compassionate basis to treat hospitalized critically ill patients infected with COVID-19.

Source: CancerNetwork - March 30, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news